| NCT03194698 |
Efficacy of IPL Treatment of Dry Eye and Ocular Rosacea |
https://ClinicalTrials.gov/show/NCT03194698 |
Completed |
Mayo Clinic |
2018-12-06 |
| NCT02749786 |
Genetic Basis of Rosacea Study (Control) |
https://ClinicalTrials.gov/show/NCT02749786 |
Completed |
Stanford University |
2016-08-01 |
| NCT02576860 |
Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle |
https://ClinicalTrials.gov/show/NCT02576860 |
Completed |
Maruho Co., Ltd. |
2017-02-27 |
| NCT03392558 |
The Suitability of Two Skin Care Regimens in Moderate to Severe Facial Rosacea |
https://ClinicalTrials.gov/show/NCT03392558 |
Completed |
Burt’s Bees Inc. |
2018-03-31 |
| NCT02601963 |
Safety and Efficacy Study of a Topical Minocycline Foam in Patients With Papulopustular Rosacea |
https://ClinicalTrials.gov/show/NCT02601963 |
Completed |
Foamix Ltd. |
2016-08-31 |
| NCT03380390 |
Safety and Tolerability of Oxymetazoline and Energy-Based Therapy in Participants With Rosacea |
https://ClinicalTrials.gov/show/NCT03380390 |
Completed |
Aclaris Therapeutics, Inc. |
2018-06-15 |
| NCT01451619 |
A Study of Laropiprant (MK-0524) in Participants With Moderate to Severe Erythematotelangiectatic Rosacea (MK-0524-155) |
https://ClinicalTrials.gov/show/NCT01451619 |
Completed |
Merck Sharp & Dohme Corp. |
2012-04-30 |
| NCT01045551 |
Open Label Pilot Study of Apremilast in Treatment of Rosacea |
https://ClinicalTrials.gov/show/NCT01045551 |
Completed |
Columbia University |
2013-01-31 |
| NCT03352323 |
An Evaluation of the Reduction in Erythema in Adult Patients With Moderate to Severe Persistent Facial Erythema Associated With Rosacea |
https://ClinicalTrials.gov/show/NCT03352323 |
Completed |
Perrigo Company |
2017-12-06 |
| NCT03287791 |
A Study to Evaluate Safety and Equivalence of Generic Azelaic Acid Foam and Finacea® Foam in Participants With Rosacea |
https://ClinicalTrials.gov/show/NCT03287791 |
Completed |
Actavis Inc. |
2017-06-22 |
| NCT03263273 |
Study to Evaluate the Safety and Efficacy of Topical Minocycline Gel in Patients With Papulopustular Rosacea |
https://ClinicalTrials.gov/show/NCT03263273 |
Completed |
Hovione Scientia Limited |
2019-03-01 |
| NCT03142451 |
A Study to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam in the Treatment of Facial Papulopustular Rosacea |
https://ClinicalTrials.gov/show/NCT03142451 |
Completed |
Foamix Ltd. |
2018-09-28 |
| NCT03094403 |
To Evaluate the Therapeutic Equivalence and Safety of Azelaic Acid 15% Topical Gel |
https://ClinicalTrials.gov/show/NCT03094403 |
Completed |
Taro Pharmaceuticals USA |
2017-03-31 |
| NCT03079531 |
Open Label Study to Assess the Effect of Secukinumab in Moderate to Severe Papulopustular Rosacea |
https://ClinicalTrials.gov/show/NCT03079531 |
Completed |
Stanford University |
2019-01-25 |
| NCT03075891 |
Oracea Soolantra Association in Patients With Severe Rosacea |
https://ClinicalTrials.gov/show/NCT03075891 |
Completed |
Galderma |
2018-02-08 |
| NCT01735201 |
AGN-199201 for the Treatment of Erythema With Rosacea |
https://ClinicalTrials.gov/show/NCT01735201 |
Completed |
Allergan |
2013-05-31 |
| NCT03050086 |
Open Label Phase 2 Feasibility Study of BPX-04 Topical Minocycline Gel in Rosacea |
https://ClinicalTrials.gov/show/NCT03050086 |
Completed |
BioPharmX, Inc. |
2018-06-19 |
| NCT03048058 |
Internet Surveys and Their Impact on Adherence for Rosacea |
https://ClinicalTrials.gov/show/NCT03048058 |
Completed |
Wake Forest University Health Sciences |
2017-06-30 |
| NCT03035955 |
Azelaic Acid on Demodex Counts in Rosacea |
https://ClinicalTrials.gov/show/NCT03035955 |
Completed |
Wake Forest University Health Sciences |
2012-02-02 |
| NCT03003104 |
DMT210 Topical Gel in the Treatment of Acne Rosacea |
https://ClinicalTrials.gov/show/NCT03003104 |
Completed |
Dermata Therapeutics |
2017-08-30 |
| NCT02132117 |
Safety and Efficacy of Oxymetazoline HCl Cream 1.0% in Patients With Persistent Erythema Associated With Rosacea |
https://ClinicalTrials.gov/show/NCT02132117 |
Completed |
Allergan |
2015-04-30 |
| NCT02840461 |
Clinical Endpoint Study of Ivermectin 1% Cream |
https://ClinicalTrials.gov/show/NCT02840461 |
Completed |
Actavis Inc. |
2016-11-30 |
| NCT02828241 |
A Study to Assess the Efficacy, Safety and Tolerability of DFD-04 |
https://ClinicalTrials.gov/show/NCT02828241 |
Completed |
Dr. Reddy’s Laboratories Limited |
2017-01-31 |
| NCT01398280 |
Effects of Aminocaproic Acid (ACA) on Rosacea-specific Inflammation |
https://ClinicalTrials.gov/show/NCT01398280 |
Completed |
University of California, San Diego |
2012-12-31 |
| NCT02616250 |
MirvasO Soolantra Association In the Treatment of Moderate to Severe rosaCea. |
https://ClinicalTrials.gov/show/NCT02616250 |
Completed |
Galderma |
2016-09-30 |
| NCT02583009 |
A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Rosacea |
https://ClinicalTrials.gov/show/NCT02583009 |
Completed |
Amorepacific Corporation |
2016-08-31 |
| NCT02576847 |
Study to Evaluate the Long-term Safety of a Once-Daily Omiganan Topical Gel |
https://ClinicalTrials.gov/show/NCT02576847 |
Completed |
Maruho Co., Ltd. |
2017-07-14 |
| NCT02547441 |
Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle |
https://ClinicalTrials.gov/show/NCT02547441 |
Completed |
Maruho Co., Ltd. |
2017-07-05 |
| NCT02028286 |
A 21 Day Pharmacokinetics Study in Papulopustular Rosacea |
https://ClinicalTrials.gov/show/NCT02028286 |
Completed |
Maruho Co., Ltd. |
2014-03-31 |
| NCT02393937 |
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea |
https://ClinicalTrials.gov/show/NCT02393937 |
Completed |
bioRASI, LLC |
2015-07-31 |
| NCT02385240 |
Comparative Safety and Efficacy of Two Rosacea Products in the Treatment of Facial Erythema of Rosacea |
https://ClinicalTrials.gov/show/NCT02385240 |
Completed |
Perrigo Company |
2015-12-31 |
| NCT02300129 |
Effect of CD07805/47 Gel in Rosacea Flushing |
https://ClinicalTrials.gov/show/NCT02300129 |
Completed |
Galderma R&D |
2014-06-30 |
| NCT02289352 |
Randomized, Double-blind, Multiple-site, Placebo-controlled, Parallel-design Study in Patients With Moderate to Severe Facial Erythema Associated With Rosacea |
https://ClinicalTrials.gov/show/NCT02289352 |
Completed |
Actavis Inc. |
2014-12-31 |
| NCT02268474 |
Excel V 532 nm KTP Laser for Treatment of Erythematotelangiectatic Rosacea & Papulopustular Rosacea |
https://ClinicalTrials.gov/show/NCT02268474 |
Completed |
Cutera Inc. |
2015-08-31 |
| NCT02249065 |
Mirvaso in Use Study |
https://ClinicalTrials.gov/show/NCT02249065 |
Completed |
Galderma Laboratories, L.P. |
2015-08-31 |
| NCT03276936 |
A Study to Evaluate the Long-Term Safety of Topical Administration of FMX103 in the Treatment of Moderate to Severe Papulopustular Rosacea |
https://ClinicalTrials.gov/show/NCT03276936 |
Completed |
Foamix Ltd. |
2019-01-03 |
| NCT02147691 |
Finacea 15% and Brimonidine 0.33% Gel in the Treatment of Rosacea - A Pilot Study |
https://ClinicalTrials.gov/show/NCT02147691 |
Completed |
Derm Research, PLLC |
2015-01-31 |
| NCT02144181 |
Ultherapy® for the Treatment of Erythematotelangiectatic Rosacea |
https://ClinicalTrials.gov/show/NCT02144181 |
Completed |
Merz North America, Inc. |
2015-12-31 |
| NCT02131636 |
Efficacy and Safety of AGN-199201 in Patients With Persistent Erythema Associated With Rosacea |
https://ClinicalTrials.gov/show/NCT02131636 |
Completed |
Allergan |
2014-11-30 |
| NCT02120924 |
A Study to Evaluate the Safety and Clinical Study of Azelaic Acid Gel 15% in Patients With Moderate Facial Rosacea |
https://ClinicalTrials.gov/show/NCT02120924 |
Completed |
Actavis Inc. |
2014-09-30 |
| NCT02095158 |
A Long-Term Safety and Efficacy Study AGN-19920 in Patients With Persistent Erythema Associated With Rosacea |
https://ClinicalTrials.gov/show/NCT02095158 |
Completed |
Allergan |
2015-08-31 |
| NCT01308619 |
Evaluation of Rosacea-related Inflammatory Biochemical Markers in Adult Skin When Treated With Oracea® vs Placebo |
https://ClinicalTrials.gov/show/NCT01308619 |
Completed |
Galderma Laboratories, L.P. |
2012-08-31 |
| NCT02052999 |
Study to Evaluate the Efficacy and Safety of PAC-14028 Cream in Rosacea Patients |
https://ClinicalTrials.gov/show/NCT02052999 |
Completed |
Amorepacific Corporation |
2013-06-30 |
| NCT03841032 |
4 Week In-Use Study Evaluating How Well-Tolerated a Skin Care Product Is on Adults With Facial Redness |
https://ClinicalTrials.gov/show/NCT03841032 |
Completed |
Bayer |
2019-02-25 |
| NCT01993446 |
A Safety and Efficacy Study of DRM02 in Subjects With Rosacea |
https://ClinicalTrials.gov/show/NCT01993446 |
Completed |
Dermira, Inc. |
2014-02-28 |
| NCT01872715 |
Patient Centered Outcomes in Rosacea: An Exploratory Multi-media Analysis of the Patient Experience on Oracea |
https://ClinicalTrials.gov/show/NCT01872715 |
Completed |
Galderma Laboratories, L.P. |
2013-06-30 |
| NCT01789775 |
Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema of Rosacea |
https://ClinicalTrials.gov/show/NCT01789775 |
Completed |
Galderma R&D |
2013-10-31 |
| NCT01784133 |
A Twelve Week Safety and Efficacy Study in Rosacea |
https://ClinicalTrials.gov/show/NCT01784133 |
Completed |
Maruho Co., Ltd. |
2014-03-31 |
| NCT01756027 |
Feasibility Study: Ulthera System for the Treatment of Rosacea |
https://ClinicalTrials.gov/show/NCT01756027 |
Completed |
Merz North America, Inc. |
2013-05-31 |
| NCT01740934 |
A Study to Evaluate the Safety, Tolerability, and Effects of Anatabloc® Crème in Rosacea |
https://ClinicalTrials.gov/show/NCT01740934 |
Completed |
Rock Creek Pharmaceuticals, Inc. |
2013-08-31 |
| NCT01666509 |
Efficacy and Tolerability of Topical Rossoseqâ„¢ Compared to Vehicle in Rosacea Subtype 1 (Erythematotelangiectatic) |
https://ClinicalTrials.gov/show/NCT01666509 |
Completed |
PBB Entrepreneur Ltd. |
2012-12-31 |
| NCT01618864 |
Safety and Efficacy of the Luxe Device to Treat Facial Wrinkles and Rosacea |
https://ClinicalTrials.gov/show/NCT01618864 |
Completed |
Syneron Medical |
2012-12-31 |
| NCT01631656 |
Combination Gel and Vascular ND in Mild to Moderate Rosacea |
https://ClinicalTrials.gov/show/NCT01631656 |
Completed |
Wake Forest University Health Sciences |
2011-02-28 |
| NCT01579084 |
Safety and Tolerability of AGN-199201 in Patients With Erythema Associated With Rosacea |
https://ClinicalTrials.gov/show/NCT01579084 |
Completed |
Allergan |
2012-06-30 |
| NCT01555463 |
Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea |
https://ClinicalTrials.gov/show/NCT01555463 |
Completed |
LEO Pharma |
2014-01-31 |
| NCT01513863 |
A Therapeutic Equivalence Study of Two Metronidazole 1%Topical Gel Treatments for Patients With Rosacea |
https://ClinicalTrials.gov/show/NCT01513863 |
Completed |
Taro Pharmaceuticals USA |
2012-06-30 |
| NCT01493947 |
CD5024 1% [Ivermectin 1%] Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study |
https://ClinicalTrials.gov/show/NCT01493947 |
Completed |
Galderma R&D |
2013-12-31 |
| NCT01493687 |
Phase 3 Papulopustular Rosacea Study |
https://ClinicalTrials.gov/show/NCT01493687 |
Completed |
Galderma |
2013-07-31 |
| NCT01318733 |
Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea |
https://ClinicalTrials.gov/show/NCT01318733 |
Completed |
Galderma |
2012-06-30 |
| NCT01449591 |
Safety, Tolerability and Efficacy of BFH772 in Rosacea Patients |
https://ClinicalTrials.gov/show/NCT01449591 |
Completed |
Novartis |
2012-02-29 |
| NCT01426269 |
Evaluation of Relapse, Efficacy and Safety of Long-term Treatment With Oracea® vs Placebo |
https://ClinicalTrials.gov/show/NCT01426269 |
Completed |
Galderma Laboratories, L.P. |
2013-06-30 |
| NCT01355471 |
Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea |
https://ClinicalTrials.gov/show/NCT01355471 |
Completed |
Galderma |
2011-11-30 |
| NCT01355458 |
Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea |
https://ClinicalTrials.gov/show/NCT01355458 |
Completed |
Galderma |
2011-09-30 |
| NCT04419259 |
Efficacy and Tolerability of Erenumab in the Management of Persistent Redness and Flushing in Rosacea |
https://ClinicalTrials.gov/show/NCT04419259 |
Recruiting |
Danish Headache Center |
2021-03-31 |
| NCT04336163 |
Skin Imaging to Inform Laser Treatments |
https://ClinicalTrials.gov/show/NCT04336163 |
Recruiting |
University of California, Irvine |
2020-12-31 |
| NCT02795117 |
Comparative Safety and Efficacy of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea |
https://ClinicalTrials.gov/show/NCT02795117 |
Completed |
Perrigo Company |
2017-02-28 |
| NCT04153188 |
Pulsed Dye Laser Treatment and Oxymetazoline Hydrochloride (HCL) 1% Cream for Erythematotelangiectatic Rosacea |
https://ClinicalTrials.gov/show/NCT04153188 |
Recruiting |
Candela Corporation |
2022-01-31 |
| NCT04108897 |
Analysis of the Microbiome in Rosacea |
https://ClinicalTrials.gov/show/NCT04108897 |
Active, not recruiting |
Johns Hopkins University |
2022-09-30 |
| NCT04106726 |
Bioequivalence Study of Ivermectin Cream 1% in Treatment of Moderate to Severe Facial Rosacea |
https://ClinicalTrials.gov/show/NCT04106726 |
Active, not recruiting |
Zydus Worldwide DMCC |
2020-07-31 |
| NCT03989492 |
Role of the Sympathetic Nervous System in Rosacea |
https://ClinicalTrials.gov/show/NCT03989492 |
Recruiting |
Indiana University |
2020-08-31 |
| NCT02806414 |
Evaluation of the Inhibitory Effects of Topical Ivermectin on Markers of Rosacea Specific Inflammation. |
https://ClinicalTrials.gov/show/NCT02806414 |
Completed |
University of California, San Diego |
2019-07-31 |
| NCT03954444 |
A Clinical Endpoint Bioequivalence Study of “Oxymetazoline Hydrochloride Cream” |
https://ClinicalTrials.gov/show/NCT03954444 |
Completed |
Actavis Inc. |
2020-01-07 |
| NCT03864978 |
Safety and Efficacy of Rifaximin in Patients With Papulopustular Rosacea and Positive Lactulose Breath Test |
https://ClinicalTrials.gov/show/NCT03864978 |
Recruiting |
Alfasigma S.p.A. |
2020-04-30 |
| NCT03756389 |
Evaluation of Topical Application of BMX-010 in Subjects With Rosacea |
https://ClinicalTrials.gov/show/NCT03756389 |
Recruiting |
BioMimetix JV, LLC |
2022-09-30 |
| NCT03689010 |
To Evaluate the Therapeutic Equivalence and Safety in Treatment of Moderate Facial Rosacea |
https://ClinicalTrials.gov/show/NCT03689010 |
Completed |
Taro Pharmaceuticals USA |
2018-08-09 |
| NCT03667222 |
Topical Minocycline Gel for Inflammatory Lesions of Papulopustular Rosacea |
https://ClinicalTrials.gov/show/NCT03667222 |
Active, not recruiting |
BioPharmX, Inc. |
2019-05-17 |
| NCT03655197 |
Lipidome and Microbiome Profile of the Eye in Rosacea |
https://ClinicalTrials.gov/show/NCT03655197 |
Active, not recruiting |
University of California, Davis |
2021-01-31 |
| NCT03340961 |
A Controlled Study to Assess the Efficacy, Safety and Tolerability of Oral DFD-29 Extended Release Capsules |
https://ClinicalTrials.gov/show/NCT03340961 |
Completed |
Dr. Reddy’s Laboratories Limited |
2018-11-07 |
| NCT03590366 |
A Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Rosacea |
https://ClinicalTrials.gov/show/NCT03590366 |
Completed |
AOBiome LLC |
2019-02-11 |
| NCT03564145 |
A Long Term Safety Study of S5G4T-1 in the Treatment of Papulopustular Rosacea |
https://ClinicalTrials.gov/show/NCT03564145 |
Completed |
Sol-Gel Technologies, Ltd. |
2020-01-24 |
| NCT03564119 |
A Study of S5G4T-1 in the Treatment of Papular-Pustular Rosacea |
https://ClinicalTrials.gov/show/NCT03564119 |
Completed |
Sol-Gel Technologies, Ltd. |
2019-06-30 |
| NCT03478436 |
Pharmacokinetics of Doxycycline in Skin of Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT03478436 |
Completed |
Medical University of Vienna |
2016-10-25 |
| NCT03472859 |
Treatment of Dilated Blood Vessels on the Cheeks With a New Yellow Laser and a Traditional Green Laser |
https://ClinicalTrials.gov/show/NCT03472859 |
Completed |
Tampere University Hospital |
2018-06-09 |
| NCT03448939 |
A Study of S5G4T-1 in the Treatment of Papulopustular Rosacea |
https://ClinicalTrials.gov/show/NCT03448939 |
Completed |
Sol-Gel Technologies, Ltd. |
2019-05-31 |
| NCT03418610 |
Azelaic Acid Foam 15% in the Treatment of Papulopustular Rosacea |
https://ClinicalTrials.gov/show/NCT03418610 |
Completed |
Clinical Research Center of the Carolinas |
2019-01-09 |
| NCT01257919 |
Safety and Pharmacokinetics of Azelaic Acid Foam, 15% in Papulopustular Rosacea |
https://ClinicalTrials.gov/show/NCT01257919 |
Completed |
LEO Pharma |
2011-03-31 |
| NCT01174030 |
Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea |
https://ClinicalTrials.gov/show/NCT01174030 |
Completed |
Galderma |
2010-12-31 |
| NCT01186068 |
Dose Response Study of Patients With Erythematous Rosacea |
https://ClinicalTrials.gov/show/NCT01186068 |
Completed |
Vicept Therapeutics, Inc. |
NA |
| NCT01025635 |
Safety and Efficacy of Azelaic Acid Foam, 15% in Papulopustular Rosacea |
https://ClinicalTrials.gov/show/NCT01025635 |
Completed |
LEO Pharma |
2010-08-31 |
| NCT01016782 |
Study of 0444 Gel in the Treatment of Inflammatory Lesions of Rosacea |
https://ClinicalTrials.gov/show/NCT01016782 |
Completed |
Fougera Pharmaceuticals Inc. |
2009-07-31 |
| NCT00991198 |
The Role of Topically Dissolved Oxygen (TDO) to Ameliorate Signs of Photodamage |
https://ClinicalTrials.gov/show/NCT00991198 |
Completed |
Aria Aesthetics Inc. |
2010-01-31 |
| NCT00989014 |
Dose-Finding Study of CD07805/47 Topical Gel in Subjects With Erythematotelangiectatic Rosacea |
https://ClinicalTrials.gov/show/NCT00989014 |
Completed |
Galderma |
2009-11-30 |
| NCT00945373 |
Combination Therapy for the Treatment of Rosacea |
https://ClinicalTrials.gov/show/NCT00945373 |
Completed |
Icahn School of Medicine at Mount Sinai |
2010-05-31 |
| NCT00940992 |
A Study of DER 45-EV Gel to Treat Rosacea |
https://ClinicalTrials.gov/show/NCT00940992 |
Completed |
Sol-Gel Technologies, Ltd. |
2012-09-30 |
| NCT00892281 |
ORCA - Oracea® for Rosacea: A Community-based Assessment |
https://ClinicalTrials.gov/show/NCT00892281 |
Completed |
Galderma Laboratories, L.P. |
2009-10-31 |
| NCT00882531 |
Isotretinoin in Papular-Pustular Rosacea |
https://ClinicalTrials.gov/show/NCT00882531 |
Completed |
Laboratoires Bailleul-Biorga |
2009-08-31 |
| NCT00855595 |
Efficacy of Topical Azelaic Acid 15% Gel Plus Anti-inflammatory Dose Doxycycline or Metronidazole Gel 1% Plus Anti-inflammatory Dose Doxycycline in Moderate Papulopustular Rosacea |
https://ClinicalTrials.gov/show/NCT00855595 |
Completed |
LEO Pharma |
2009-04-30 |
| NCT03878784 |
PACAP38 Induced Headache and Rosacea-like Symptoms in Patients With Rosacea |
https://ClinicalTrials.gov/show/NCT03878784 |
Completed |
Danish Headache Center |
2019-12-19 |
| NCT02774590 |
Timolol for the Treatment of Acne and Rosacea |
https://ClinicalTrials.gov/show/NCT02774590 |
Recruiting |
Johns Hopkins University |
2025-03-31 |
| NCT01885000 |
Patient-Reported Outcome Of Facial Erythema (PROOF) |
https://ClinicalTrials.gov/show/NCT01885000 |
Completed |
Galderma |
2013-11-30 |
| NCT01529996 |
Pulsed Dye Laser (PDL) vs. Microsecond 1064-nm Nd:YAG Laser for Treatment of Diffuse Facial Redness |
https://ClinicalTrials.gov/show/NCT01529996 |
Completed |
Northwestern University |
2012-08-31 |
| NCT02800148 |
Bioequivalence Study of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea on the Face |
https://ClinicalTrials.gov/show/NCT02800148 |
Completed |
Perrigo Company |
2017-10-31 |
| NCT02066051 |
IPL and Meibomian Gland Expression to Treat Ocular Rosacea Ocular GVHD |
https://ClinicalTrials.gov/show/NCT02066051 |
Completed |
Mayo Clinic |
2014-11-30 |
| NCT01933464 |
An Analysis of the Effect of Topical Cromolyn Sodium on Rosacea-associated Erythema |
https://ClinicalTrials.gov/show/NCT01933464 |
Completed |
University of California, San Diego |
2014-02-28 |
| NCT01659853 |
Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea |
https://ClinicalTrials.gov/show/NCT01659853 |
Completed |
Galderma Laboratories, L.P. |
2012-12-31 |
| NCT01494467 |
Phase 3 Papulopustular Rosacea Study |
https://ClinicalTrials.gov/show/NCT01494467 |
Completed |
Galderma |
2013-08-31 |
| NCT00697541 |
Systemic Bioavailability Study Of Col-118 Administered Topically as a 0.18 % Facial Gel And Brimonidine Ophthalmic Solution 0.2% |
https://ClinicalTrials.gov/show/NCT00697541 |
Completed |
Galderma |
2008-06-30 |
| NCT00681603 |
Safety and Effectiveness of Subconjunctival Injection of Bevacizumab in the Treatment of Corneal Neovasculization |
https://ClinicalTrials.gov/show/NCT00681603 |
Completed |
National Taiwan University Hospital |
2008-02-29 |
| NCT00667173 |
A Clinical Study Evaluating the Safety and Efficacy of IDP-115 in Patients With Rosacea |
https://ClinicalTrials.gov/show/NCT00667173 |
Completed |
Dow Pharmaceutical Sciences |
2008-07-31 |
| NCT02075671 |
Photodynamic Therapy for Papulopustular Rosacea |
https://ClinicalTrials.gov/show/NCT02075671 |
Recruiting |
George Washington University |
2019-02-28 |
| NCT00621218 |
A Study to Determine the Safety and Efficacy of Atralin (Tretinoin 0.05%) Gel for the Treatment of Rosacea |
https://ClinicalTrials.gov/show/NCT00621218 |
Completed |
Coria Laboratories, Ltd. |
2008-04-30 |
| NCT00617903 |
Exploration of Safety and Efficacy of AzA 15% Foam Twice a Day in Rosacea |
https://ClinicalTrials.gov/show/NCT00617903 |
Completed |
LEO Pharma |
2008-06-30 |
| NCT00580723 |
Effects of PRK 124 Lotion in Acne Rosacea |
https://ClinicalTrials.gov/show/NCT00580723 |
Completed |
University of California, Irvine |
2009-02-28 |
| NCT00560703 |
Treatment of Patients With Blepharitis and Facial Rosacea |
https://ClinicalTrials.gov/show/NCT00560703 |
Completed |
Galderma |
2009-05-31 |
| NCT00495313 |
Safety and Efficacy Study to Compare Two Rosacea Treatment Regimens |
https://ClinicalTrials.gov/show/NCT00495313 |
Completed |
CollaGenex Pharmaceuticals |
2007-12-31 |
| NCT00436527 |
Assess the Ability of MetroGel 1% to Deliver Moisture to Facial Skin After a Single Application |
https://ClinicalTrials.gov/show/NCT00436527 |
Completed |
Galderma Laboratories, L.P. |
2006-08-31 |
| NCT00348335 |
Efficacy of Topical Cyclosporin for Ocular Rosacea |
https://ClinicalTrials.gov/show/NCT00348335 |
Completed |
Ophthalmic Consultants of Long Island |
2007-09-30 |
| NCT00279890 |
Topical Agent for Treatment of Red Skin |
https://ClinicalTrials.gov/show/NCT00279890 |
Completed |
Mayo Clinic |
2007-01-31 |
| NCT00249782 |
A Phase II, Randomized Study of ACZONEâ„¢ (Dapsone) Gel, 5% for Papulopustular Rosacea. |
https://ClinicalTrials.gov/show/NCT00249782 |
Completed |
Allergan |
2006-05-31 |
| NCT00823901 |
Safety and Efficacy Study of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel to Treat Rosacea |
https://ClinicalTrials.gov/show/NCT00823901 |
Completed |
Massachusetts General Hospital |
2010-10-31 |
| NCT00041977 |
Determine the Effect of Administering Periostat(R) Twice Daily on Patients With Acne Rosacea |
https://ClinicalTrials.gov/show/NCT00041977 |
Completed |
CollaGenex Pharmaceuticals |
NA |
| NCT00483145 |
Laser-Mediated Photodynamic Therapy of Acne Vulgaris and Rosacea |
https://ClinicalTrials.gov/show/NCT00483145 |
Completed |
Bispebjerg Hospital |
NA |
| NCT00417937 |
A Multicenter Trial of a Topical Medication for Papulopustular Rosacea Applied Twice Daily Versus Once Daily |
https://ClinicalTrials.gov/show/NCT00417937 |
Completed |
LEO Pharma |
2007-06-30 |
| NCT00126399 |
A Clinical Trial to Determine the Effects of 40 Mg Doxycycline Versus a Placebo Control for the Treatment of Rosacea |
https://ClinicalTrials.gov/show/NCT00126399 |
Completed |
CollaGenex Pharmaceuticals |
NA |